A comparative pharmaco-metabolomic study of glutaminase inhibitors in glioma stem-like cells confirms biological effectiveness but reveals differences in target-specificityKatharina Koch, Ulf D. Kahlert|Cell Death Discovery|2020Cited by 89
Scientific Validation of Human Neurosphere Assays for Developmental Neurotoxicity EvaluationKatharina Koch, Ellen Fritsche|Frontiers in Toxicology|2022Cited by 40
Alterations in cellular metabolome after pharmacological inhibition of <scp>N</scp>otch in glioblastoma cellsUlf D. Kahlert, Charles G. Eberhart, Luigi Marchionni et al.|International Journal of Cancer|2015Cited by 37
Reciprocal regulation of the cholinic phenotype and epithelial-mesenchymal transition in glioblastoma cellsKatharina Koch, Jarek Maciaczyk|Oncotarget|2016Cited by 33
Overexpression of Cystine/Glutamate Antiporter xCT Correlates with Nutrient Flexibility and ZEB1 Expression in Highly Clonogenic Glioblastoma Stem-like Cells (GSCs)Katharina Koch, Jarek Maciaczyk|Cancers|2021Cited by 14